Our friends over at VICE have an interesting piece about the unusual professions the cannabis industry is spawning, like “cannabis critics”, the people who sample new strains and tell you all about them. Since cannabis is still a Schedule 1 drug and consequently no one can do true, recorded research, dispensaries and producers have long had to rely on feedback from users in order to be able to describe their medicine’s unique qualities. At Cannaceutics, our strain characteristics and reviews come from our patients telling us how the medicine affected them.
“We are the frontline guinea pigs for legalization. We try these various strains to show that there’s a very big difference between them, and different people need them for different reasons,” [critic Jake] Browne continues. “The more that becomes normalized, the better we’ll be able to serve people.”
The normalization of the cannabis industry is important in the sense that cannabis is still seen by many people as a dangerous, addictive drug that will definitely lead to other, harder drugs. It helps to see a cannabis review in a mainstream newspaper, rather than in an alternative weekly publication, or not at all. It’s a positive thing that cannabis users come from all walks of life, from many income levels, and many segments of society. The old “stoner stereotype” doesn’t really fit the majority of patients anymore, either. Sure, you’ll still see plenty of tie-dye and Birkenstocks in dispensary waiting rooms, but you’ll see more and more professionals in business dress, parents bringing their kids with them to pick up medicine, and retired people, just like in a pharmacy.
Check out the column at VICE for a look at cannabis criticism.
Cannaceutics has been in the process of expanding to better meet our patients’ needs! Most of you have seen our new, larger waiting area, and one of our final renovations will be adding a retail section, where you can buy items like pipes, papers, and vapes. Cannaceutics will not be carrying the “cartridge” type oil vapes due to the potential health problems associated with them, so it might be a good time to look into what other types of vaporizer you might like. Leafly has a good list of a few things to consider if you’re in the market for a new vape.
Leafly’s Vape Buyer’s Guide
We’ve been hearing more and more lately from patients who are concerned about how their buds look, cosmetically. Different producers of cannabis have different methods of trimming cannabis buds, and those differences can change the quality of your medicine. At Cannaceutics, we use the John Henry method and hand-trim the medicine we produce, for several reasons. First, let’s have a look at how a common trimming machine trims buds:
Cannaceutics is proud to announce that we have begun terpene testing with Scepter Labs!
Late last year we started hearing our patients asking about terpene profiling. Most patients seek this kind of testing so they can better tailor their cannabis use to specific symptoms. Terpenes are different from cannabinoids (THC, CBD, and more) in that cannabinoids are the “medicinal” part of the plant. Cannabinoids produce pain relief and the psychoactive “high” effect of cannabis. Terpenes are different, fragrant compounds that work with cannabinoids to produce unique effects on the brain. This “synergy” between cannabinoids and terpenes are what make cannabis work better for symptoms than just cannabinoids or terpenes alone would.
The quickly changing landscape of the cannabis industry in America has patients understandably concerned. It seems like every day new reports come out of Washington, D.C. with another dire comment on “The Devil’s Lettuce” from current Attorney General Jeff Sessions. Patients are frustrated about the lack of clear answers in the issues of state’s rights to regulate the sale of legal medical or recreational cannabis versus those of the federal government, which of course considers cannabis in any form illegal.